Johnson & Johnson plans to examine the final vaccine in September

News

Johnson & Johnson plans to examine the final vaccine in September

25.08.2020 News

Shares of Johnson & Johnson rose by 0.68% on Thursday, ahead of the growth of the S&P 500 index by 0.32% after as the company announced that it plans to begin the final phase of a clinical trial of its COVID-19 vaccine in September.

Shares of J&J recovered after losses in February and March and showed an increase of 15.12% over the last year.

J&J announced that its subsidiary Janssen Vaccines intends to launch a large-scale of a study of the Ad26.COV2-S vaccine on 60,000 healthy volunteers aged 18 years and older. The company said that it used the same technology in the production of Ad26.COV2-S as in the development of the experimental vaccine against the Ebola virus.

The estimated start date is September 5, with the estimated completion date of all studies (including the effects of the vaccine) being March 10, 2023.

The final Janssen Vaccines “Phase 3” research will take place in 180 cities in the United States and other countries, including Brazil and Mexico.

“Our phase 3 program should be as reliable as possible, can include up to 60,000 participants, and will be conducted in high-prevalence areas,” – said J&J spokesman Jake Sargent in an interview with CNBC. “We use epidemiology and modeling data to predict and plan where our research will take place, and we expect it to be completed soon.”

Earlier this month, Johnson & Johnson announced a contract with the US government to provide 100 million doses of its potential vaccine for $ 1 billion.

Comparing J & J to other manufacturers vaccine candidates COVID-19, then the company lags behind them in terms: Pfizer and Moderna have already embarked on 3 phases of research. In addition, these manufacturers have received government contracts for the same 100 million doses of vaccines more expensive: Pfizer will deliver these products for $ 1.9 billion and Moderna for $ 1.53 billion. At the same time, the final studies of Moderna and Pfizer cover twice the number of volunteers – up to 30,000.

However, J&J still has a chance to emerge victorious from the race, because preclinical trials of its Ad26.COV2-S vaccine in primates have shown the formation of high levels of antibodies to fight infection with a single dose, whereas candidate vaccines from other manufacturers required two doses to obtain a similar result.

Putting one dose instead of two, it may be better for many government orders and vaccine J & J can obtain greater international fame when the calendar will include annual vaccinations.

Other articles

  • The first batch of Pfizer COVID vaccine has arrived in Israel
    News

    The first batch of Pfizer COVID vaccine has arrived in Israel

    The first batch of Pfizer coronavirus vaccine has been delivered to Israel. This was reported by The Jerusalem Post on Wednesday, December 9. “A DHL flight from Brussels carried more than 100,000 doses of the newly created vaccine and landed at Ben Gurion Airport in Tel Aviv around 9 a.m.,” the statement said. The doses […]

  • Pfizer will deliver half of the planned number of vaccines in 2020
    News

    Pfizer will deliver half of the planned number of vaccines in 2020

    Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

  • US pharmaceutical giant Pfizer will open a new hub in Greece
    News

    US pharmaceutical giant Pfizer will open a new hub in Greece

    American Pfizer is one of the world’s largest pharmaceutical companies. Greek government spokesman Stelios Petsas stated it’s expanding its presence in Greece, creating 600 workplaces. Pfizer’s chairman is Greek Albert Burla. In recent months, the company has been developing a vaccine against coronavirus. A company hub opens in Thessaloniki. “Greece is attracting big investment and […]

  • Moderna vaccine will be tested on teenagers
    News

    Moderna vaccine will be tested on teenagers

    The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]

  • Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19
    News

    Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19

    Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]

  • Britain intends to start vaccination against coronavirus in December
    News

    Britain intends to start vaccination against coronavirus in December

    The British government hopes that in the coming weeks the relevant authorities of the country will register two vaccines against coronavirus. Boris Johnson, the Prime Minister announced it in an interview with Sky News on Monday, November 30. “So far, no vaccine has been approved for use by the Medicines and Medical Devices Agency. However, […]

  • The Nikkei index has become the highest since 1991
    News

    The Nikkei index has become the highest since 1991

    Trading on Asia’s largest stock exchange on Asia on Tuesday opened another rise amid the continuing strengthening of indices in New York. This is evidenced by the data of stock trading on the website of the Tokyo Stock Exchange. The Nikkei index, which reflects fluctuations in the stock prices of 225 leading companies in the […]

  • Shares of Moderna rose by almost 20% after news of the vaccine
    News

    Shares of Moderna rose by almost 20% after news of the vaccine

    The vaccine, developed by biotechnology company Moderna, is effective in 94.5% of cases. This result was shown by the intermediate results of the third phase of clinical trials, the company said. On this news, Moderna shares went up. In the pre-market, the company’s quoting rose by more than 18%, rising above $ 105 per share. […]

Read also

Johnson & Johnson plans to examine the final vaccine in September
News

CREDIT AGRICOLE SIGNED AN AGREEMENT WITH THE EBRD AND JOINED THE “EU4BUSINESS-EBRD CREDIT LINE” PROGRAM

On 21 April, Credit Agricole signed the agreement with the European Bank for Reconstruction and Development (EBRD) and joined the «EU4Business-EBRD Credit Line» Program, within which the bank will get a EUR 25 million loan for 4 years. The purpose of the borrowing is to support micro, small, and medium-sized businesses and to expand their access to […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Tesla was not included in the index S&P 500

Tesla met all the criteria, but it was still not included in the S&P 500. Committee of the S&P Dow Jones Indices refused to include Tesla`s shares in the S&P 500. Such decision was made despite the automaker’s fulfillment of the last criterion to be included in the index – Tesla showed a profit for […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Apple has been fined by the Italian government by € 318 million

 Apple has received a fine of € 318 million from the Italian regulatory authorities. Apple is accused of violating tax laws, namely in the tax evasion in Italy by transferring funds to Ireland. During the investigation, regulatory authorities found that the company deliberately transferred funds in the amount of € 880 million to Ireland, where […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

The Swiss company has become a co-owner of the Ukrainian business Rosneft

The Swiss company Glusco Energy S.A. received the permission from the Antimonopoly Committee of Ukraine for the acquisition of a 50% stake in Rosneft Management Company Ltd and Fargrade Ltd. It became known from the information posted on the official website of the Ukrainian regulator. The cost of the transaction was not disclosed. Registered in […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

The US and the EU will end the trade dispute between Boeing and Airbus

Authorities in the United States and the European Union have agreed to end a long-running trade dispute over the aerospace concerns Boeing and Airbus, which has resulted in mutual tariffs of more than $ 10 billion, said Catherine Ty, the US representative at the trade talks. “The US-EU agreement marks significant progress in reaching a […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

The new owner of Boguslavskiy zavod prodtovariv and fish processing plant Vohni Hestii will be Fozzy Group

One of the biggest Ukrainian trade and industrial groups Fozzy Group, which is a part of PJSC Holding Invest (Kyiv), has received permission from the Antimonopoly Committee for the purchase of Boguslavskii zavod prodtovariv (Kyiv region, city Bohuslav) and a plant for fish processing Vohni hestii (legal address – Kyiv, physical address – Zhytomyr). This […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Adidas may sell Reebok

According to Bloomberg, a source familiar with the situation, German manufacturer of sportswear and accessories Adidas AG is considering the possibility of selling its brand Reebok. “In the coming months, the company will decide whether to start the sale process,” the source said. According to the interlocutor of the agency, the internal assessment of sales […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Grey Group acquires Easycom Group in China

Grey Group, one of the largest global communications networks has acquired a majority stake in Easycom, a social media agency in China. This acquisition will accelerate Grey’s growth in one of the world’s most dynamic emerging economies and offer clients access to a new vary of marketing services.  Founded in Shanghai in 2006, Easycom has a […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Denmark will stop oil and gas production in the North Sea

The Danish government will stop issuing new licenses for the development of oil and gas fields in the North Sea. The country will completely stop hydrocarbon production by 2050, according to Bloomberg. The Danish government reached an agreement with parliament late Thursday night to abandon a previously scheduled eighth round of licensing, as well as […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Tencent has offered $ 1.5 billion for video game developer Leyou Technologies

Chinese internet giant Tencent Holdings has made an offer to buy Leyou Technologies Holdings, which estimates this video game developer at 11.61 billion Hong Kong dollars ($ 1.5 billion), writes The Wall Street Journal. Tencent plans to pay for the full transaction with money, without attracting outside funding, and is willing to pay $ 3.3219 […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Named the most expensive brands in the world

Apple Inc. for the first time in 2016 ranked first in the list of most valuable brands in the world. Brand Finance analysts estimated the company at $ 263.4 billion. Amazon ($ 254.2 billion) is second in the annual Brand Finance Global 500 ranking, followed by Google ($ 191.2 billion). The top ten most expensive […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Foreigners invest nearly 300 million UAH in the furniture factory

Spouses McMahon, the owners  of the “Morgan Fenice company ” –  a large manufacturer of the upholstered furniture  (Morgan Furniture LLC, Kvasyliv,  Rivne region), are going to invest 280 million UAH (€ 9.3 million) within the next three years to expand production capacity and specialty-equipment. This will increase the volumes of production and export by […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Oil prices jumped in the US election

In the background of the general election in the United States world oil prices jumped.This is evidenced by trading data as of Monday morning, November 9. And what about the election, according to preliminary data in the presidential race the Democrat Joseph Biden wins. Thus, the price of January futures for Brent oil on the […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Warren Buffett says he’s lost $2 billion on IBM

On Friday, Buffett’s Berkshire Hathaway announced that it has lost $2 billion on its IBM investment. That’s 15% of the more than $13 billion worth of IBM’s stock that Berkshire has purchased over the past four-plus years. Berkshire says it is still committed to IBM, calling the downturn in IBM’s stock “temporary.” “IBM continues to […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Bill Gates warned against buying Bitcoin

Microsoft founder Bill Gates has warned investors against buying the cryptocurrency Bitcoin. Bloomberg reports. “If you have less money than Ilona [Mask], you probably need to be careful. Ilon has a lot of money and he’s very advanced, so I’m not worried that his bitcoins will rise and fall chaotically,” Gates said. Gates fears that […]

Next
Johnson & Johnson plans to examine the final vaccine in September
News

Tesla plans to sell shares totaling up to $ 5 billion

Tesla has agreed with a number of banks to cooperate in the sale of shares in the company totaling up to $ 5 billion, according to the US corporation. “We have entered into a share distribution agreement … under which we may from time to time offer and sell our ordinary shares with a total […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com